CD40 Mediated Activation of Gingival and Periodontal Ligament Fibroblasts

Journal of Periodontology

Volumn 68, Issue 3, 1997, Pages 284-292

  Sempowski, Gregory D ^a,b   Chess, Patricia R ^b   Moretti, Antonio J ^c   Padilla, Josué ^b,c   Phipps, Richard P ^a,b   Blieden, Timothy M ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Dept of Microbiology and Immunology ^*

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

CD40 antigens; Fibroblasts; Gingival; Interleukin 6; Periodontal ligament

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 6; LIGAND; MEMBRANE PROTEIN; T LYMPHOCYTE ANTIGEN; TYROSINE;

ARTICLE; B LYMPHOCYTE; BASOPHIL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CYTOLOGY; DENDRITIC CELL; EOSINOPHIL; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; GINGIVITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAST CELL; METABOLISM; MONOCYTE; PATHOLOGY; PERIODONTAL LIGAMENT; PERIODONTITIS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; BASOPHILS; BLOTTING, WESTERN; CD40 LIGAND; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELLS, CULTURED; DENDRITIC CELLS; EOSINOPHILS; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; GINGIVITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-6; LIGANDS; LYMPHOCYTE ACTIVATION; MAST CELLS; MEMBRANE GLYCOPROTEINS; MONOCYTES; PERIODONTAL LIGAMENT; PERIODONTITIS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TYROSINE;

EID: 0031093237     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.3.284     Document Type: Article

References (43)

1. Clark EA, Ledbetter JA. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci (USA) 1986;83:4494-4498.
2. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlman P. A p50 surface antigen restricted to human urinary bladder carcinoma and B lymphocytes. Cancer Immunol Immunoth 1985;20:23-28.
3. Hart DN, McKenzie JL. Isolation and characterization of human tonsil dendritic cells. J Exp Med 1988;168:157-170.
4. Young LS, Dawson CW, Brown KW, Rickinson AB. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 1989;43:786-794.
5. Schriever FA, Freedman S, Freeman G, et al. Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 1989;169:2043-2058.
6. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA. Temporal association of the CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of antiCD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990;76:2449-2456.
7. Law CL, Worman B, LeBien TW. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia 1990;4:732-738.
8. Galy A, Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992;149:775-782.
9. Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995;182: 33-450.
10. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE. The CD40 ligand expressed by human B cells coslimulates B cell responses. J Immunol 1995;154:4996-5010.
11. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci (USA) 1992;89:6550-6554.
12. Stamenkovic I, Clark EA, Seed B. A B cell activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989;8:1403-1410.
13. Clark EA, Shu GL, Luscher B, et al. Activation of human B cells. Comparison of the signal transduced by interleukin-4 (IL-4) to four different competence signals. J Immunol 1989;143:3873-3880.
14. Gordon J, Millsum MJ, Flores-Romo L, Gillis S. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23, and CD40. Immunol 1989;68:526-531.
15. Barrett TB, Shu G, Clark EA. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 1991;146: 1722-1729.
16. Ledbetter JA, Shu G, Gallagher M, Clark EA. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDw40). J Immunol 1987;138: 788-794.
17. Valle A, Zuber CE, Defrance T, Djossou O, De RM, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989;19:1463-1467.
18. Jabara HH, Fu SM, Geha RS, Vercelli D. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990;172:1861-1864.
19. Zhang K, Clark EA, Saxon A. CD40 stimulation provides an IFN-g-dependent and IL-4 dependent differentiation signal directly to human B cells for IgE production. J Immunol 1991;146:1836-1842.
20. Splawski JB, Fu SM, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993;150:1276-1285.
21. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991;251:70-72.
22. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991;173:705-710.
23. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. Mechanism of antigen-driven selection in germinal centres. Nature 1989;342:929-931.
24. Liu YJ, Cairns JA, Holder MJ, et al. Recombinant 25-kDa CD23 and interleukin la promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991;21:1107-1114.
25. Clark EA, Shu GL. Linkage between IL-6 and CD40 signaling: IL-6 activates the phosphorylation of CD40. J Immunol 1990;145:1400-1406.
26. MacLennan ICM, Liu Y-J, Johnson GD. Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immun Rev 1992;126:143-161.
27. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80-82.
28. Hollenbaugh D, Grosmaire LS, Kullas CD, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992;11:4313-4321.
29. Spriggs MK, Armitage RJ, Strockbine L, et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543-1550.
30. Fanslow WC, Anderson DM, Grabstein KH, Clark EA, Cosman D, Armitage RJ. Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol 1992;149:655-660.
31. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP. CD40 expression by human fibroblasts. Clin Immunol Immunop 1995;77:42-51.
32. Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Ann Rev Immunol 1994;12:881-922.
33. Faris M, Gaskin F, Parsons JT, Fu SM. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylaled protein. J Exp Med 1994;179:1923-1931.
34. Fries KM, Felch ME, Phipps RP. Interleukin 6 is an autocrine growth factor for murine fibroblast subsets. Am J Resp Cell Molec Biol 1994;11:552-560.
35. Guillot JL, Pollock SM, Johnson RB. Gingival IL-6 concentration following phase I therapy. J Periodontol 1995;66:667-672.
36. McCulloch CAG, Bordin S. Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodont Res 1991;26: 144-154.
37. Foy TM, Durie FH, Noelle RJ. The expansive role of CD40 and its ligand, gp39, in immunity. Seminars Immunol 1994;6:259-266.
38. Page RC, Schroeder H. Periodontitis in Man and Other Animals. Basel; S. Karger: 1982;22-41.
39. Genco RJ. Host responses in periodontal diseases: Current concepts. J Periodontol 1992;63:338-355.
40. Frei K, Leist TP, Meager A, et al. Production of B-cell stimulatory factor-2 and Interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med 1988;168:449-453.
41. Helfgott DC, Tatter SB, Santhanam U, et al. Multiple forms of IFN-b2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 1989;142:948-953.
42. Bordin JS, Kolb WP, Page RC. CIq receptors on cultured human gingival fibroblasts: analysis of binding properties. J Immunol 1983;130:1871-1875.
43. Bordin S, Page RC, Narayanan AS. Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science 1984;223:171-173.